Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.

C Pozzo; C Barone; J Szanto; E Padi; C Peschel; Johannes Bükki; V Gorbunova; V Valvere; J Zaluski; M Biakhov; E Zuber; C Jacques; R Bugat

doi:10.1093/annonc/mdh473

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.

C Pozzo, C Barone, J Szanto, E Padi, C Peschel, Johannes Bükki, V Gorbunova, V Valvere, J Zaluski, M Biakhov, E Zuber, C Jacques, R Bugat

Institute of Nursing Science and Practice

Research output: Contribution to journal › Original Article › peer-review

128 Citations (Web of Science)

Original language	English
Pages (from-to)	1773-1781
Journal	ANNALS OF ONCOLOGY
Volume	15
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdh473
Publication status	Published - 2004

Keywords

METASTATIC COLORECTAL-CANCER
HIGH-DOSE METHOTREXATE
PLUS SUPPORTIVE CARE
EUROPEAN-ORGANIZATION
ADJUVANT CHEMOTHERAPY
FLUOROURACIL FAILURE
COOPERATIVE GROUP
TRIAL
DOXORUBICIN
LEUCOVORIN

Access to Document

10.1093/annonc/mdh473

Cite this

Pozzo, C., Barone, C., Szanto, J., Padi, E., Peschel, C., Bükki, J., Gorbunova, V., Valvere, V., Zaluski, J., Biakhov, M., Zuber, E., Jacques, C., & Bugat, R. (2004). Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. ANNALS OF ONCOLOGY , 15(12), 1773-1781. https://doi.org/10.1093/annonc/mdh473

Pozzo, C ; Barone, C ; Szanto, J et al. / Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. In: ANNALS OF ONCOLOGY 2004 ; Vol. 15, No. 12. pp. 1773-1781.

@article{92f8f1f4402d42f0a19bc0f1a9db0633,

title = "Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.",

keywords = "METASTATIC COLORECTAL-CANCER, HIGH-DOSE METHOTREXATE, PLUS SUPPORTIVE CARE, EUROPEAN-ORGANIZATION, ADJUVANT CHEMOTHERAPY, FLUOROURACIL FAILURE, COOPERATIVE GROUP, TRIAL, DOXORUBICIN, LEUCOVORIN",

author = "C Pozzo and C Barone and J Szanto and E Padi and C Peschel and Johannes B{\"u}kki and V Gorbunova and V Valvere and J Zaluski and M Biakhov and E Zuber and C Jacques and R Bugat",

year = "2004",

doi = "10.1093/annonc/mdh473",

language = "English",

volume = "15",

pages = "1773--1781",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

number = "12",

}

Pozzo, C, Barone, C, Szanto, J, Padi, E, Peschel, C, Bükki, J, Gorbunova, V, Valvere, V, Zaluski, J, Biakhov, M, Zuber, E, Jacques, C & Bugat, R 2004, 'Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.', ANNALS OF ONCOLOGY , vol. 15, no. 12, pp. 1773-1781. https://doi.org/10.1093/annonc/mdh473

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. / Pozzo, C; Barone, C; Szanto, J et al.
In: ANNALS OF ONCOLOGY , Vol. 15, No. 12, 2004, p. 1773-1781.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.

AU - Pozzo, C

AU - Barone, C

AU - Szanto, J

AU - Padi, E

AU - Peschel, C

AU - Bükki, Johannes

AU - Gorbunova, V

AU - Valvere, V

AU - Zaluski, J

AU - Biakhov, M

AU - Zuber, E

AU - Jacques, C

AU - Bugat, R

PY - 2004

Y1 - 2004

KW - METASTATIC COLORECTAL-CANCER

KW - HIGH-DOSE METHOTREXATE

KW - PLUS SUPPORTIVE CARE

KW - EUROPEAN-ORGANIZATION

KW - ADJUVANT CHEMOTHERAPY

KW - FLUOROURACIL FAILURE

KW - COOPERATIVE GROUP

KW - TRIAL

KW - DOXORUBICIN

KW - LEUCOVORIN

U2 - 10.1093/annonc/mdh473

DO - 10.1093/annonc/mdh473

M3 - Original Article

C2 - 15550582

SN - 0923-7534

VL - 15

SP - 1773

EP - 1781

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

IS - 12

ER -

Pozzo C, Barone C, Szanto J, Padi E, Peschel C, Bükki J et al. Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. ANNALS OF ONCOLOGY . 2004;15(12):1773-1781. doi: 10.1093/annonc/mdh473